| Literature DB >> 19903164 |
Chiranjib Chakraborty1, Chi-Hsin Hsu, Zhi-Hong Wen, Chan-Shing Lin.
Abstract
The chemical and biological diversity of the different marine evolutionary group is endless and therefore, this is an amazing resource for the discovery of new anticancer drugs. Comprising 34 of the 36 Phyla of life, marine ecosystems are indeed our last genetic diversity and biotechnological boundary; terrestrial systems possess only 17 Phyla. Sponges, coelenterates and microorganisms are the foremost resources of therapeutic compounds. Algae, echinoderms, tunicates, mollusks, bryozoans are also the sources of anticancer drugs from marine resources. We highlight the past and current status of marine anticancer pharmacology using different marine groups.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19903164 DOI: 10.2174/156802609789909803
Source DB: PubMed Journal: Curr Top Med Chem ISSN: 1568-0266 Impact factor: 3.295